We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-11.63%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.35B
AUM Growth
-$150M
Cap. Flow
+$56.3M
Cap. Flow %
4.16%
Top 10 Hldgs %
19.09%
Holding
2,522
New
117
Increased
687
Reduced
642
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 5.94%
2 Energy 5.6%
3 Industrials 5.47%
4 Healthcare 5.28%
5 Financials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLTR icon
676
Dollar Tree
DLTR
$24.9B
$157K 0.01%
1,796
+50
+3% +$4.22K
NEM icon
677
Newmont
NEM
$100B
$157K 0.01%
4,575
-200
-4% -$6.48K
PHYS icon
678
Sprott Physical Gold
PHYS
$14.6B
$156K 0.01%
15,150
CRM icon
679
Salesforce
CRM
$152B
$155K 0.01%
1,155
+75
+7% +$10.3K
JCE icon
680
Nuveen Core Equity Alpha Fund
JCE
$284M
$154K 0.01%
13,015
+160
+1% +$2.16K
CORP icon
681
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
$153K 0.01%
1,552
+1
+0.1% +$99
OBK icon
682
Origin Bancorp
OBK
$1.69B
$153K 0.01%
4,500
+500
+13% +$18.3K
WDAY icon
683
Workday
WDAY
$40.8B
$153K 0.01%
962
+158
+20% +$22.4K
ADC icon
684
Agree Realty
ADC
$9.24B
$152K 0.01%
2,575
-42
-2% -$2.4K
DLR icon
685
Digital Realty Trust
DLR
$70.7B
$152K 0.01%
1,437
-32
-2% -$3.54K
DXCM icon
686
DexCom
DXCM
$32.9B
$152K 0.01%
5,148
+400
+8% +$12.7K
WST icon
687
West Pharmaceutical
WST
$24.5B
$152K 0.01%
1,582
BSJL
688
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
$152K 0.01%
6,450
-200
-3% -$4.86K
DGX icon
689
Quest Diagnostics
DGX
$25.6B
$150K 0.01%
1,830
+63
+4% +$5.91K
MLAB icon
690
Mesa Laboratories
MLAB
$584M
$150K 0.01%
728
VT icon
691
Vanguard Total World Stock ETF
VT
$78B
$150K 0.01%
2,314
-341
-13% -$23.9K
CM icon
692
Canadian Imperial Bank of Commerce
CM
$109B
$149K 0.01%
4,016
ISTB icon
693
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
$149K 0.01%
3,042
LNC icon
694
Lincoln National
LNC
$8.82B
$149K 0.01%
2,929
-7,105
-71% -$432K
TMO icon
695
Thermo Fisher Scientific
TMO
$213B
$149K 0.01%
671
-1
-0.1% -$235
CCI icon
696
Crown Castle
CCI
$33.5B
$148K 0.01%
1,377
-42
-3% -$4.62K
FYC icon
697
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.3B
$148K 0.01%
3,730
+78
+2% +$3.5K
PEO
698
Adams Natural Resources Fund
PEO
$739M
$148K 0.01%
10,696
SIL icon
699
Global X Silver Miners ETF NEW
SIL
$4.07B
$148K 0.01%
5,947
-100
-2% -$2.41K
FMB icon
700
First Trust Managed Municipal ETF
FMB
$2.05B
$147K 0.01%
2,795
-700
-20% -$36.5K

Similar funds

Geneos Wealth Management's Q4 2018 Portfolio in Review

As of Q4 2018, Geneos Wealth Management held 2,522 positions worth $1.35B, down 10% from $1.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $56.3M of net new capital in Q4 2018, opening 117 new positions and adding to 687 existing holdings. Its largest new stake was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.5% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $9.44M trimmed.

  • Geneos Wealth Management's largest Q4 2018 buy was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.
  • Geneos Wealth Management added most to iShares Russell 1000 ETF in Q4 2018, an estimated $16M increase.
  • Geneos Wealth Management's biggest Q4 2018 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $9.44M.
  • Geneos Wealth Management fully exited ProShares Ultra Consumer Discretionary in Q4 2018, selling an estimated $4.08M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $1.35B portfolio in Q4 2018.
  • Geneos Wealth Management opened 117 new positions and closed 145 in Q4 2018.
  • Geneos Wealth Management's portfolio value fell 10% quarter-over-quarter to $1.35B.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.